Back to Advanced Topics
iCGM Interoperability and System Integration
FDA interoperability standards enable CGMs and insulin pumps from different manufacturers to work together safely.
Reviewed by CGM AFIA Editorial Team. Last reviewed: 2026-01-24.
Author: CGM AFIA Editorial Team
The Vision of Interoperability
Interoperability standards allow diabetes devices from different manufacturers to communicate and work together seamlessly.
FDA Framework
iCGM (Integrated CGM)
Special controls for CGMs intended to work with automated insulin delivery systems.
ACE Pump
Alternate Controller Enabled insulin pump designation for devices that can receive commands from external algorithms.
Benefits of Interoperability
For Patients
- Choose best-in-class components
- Not locked into single manufacturer
- More options for personal preferences
For Innovation
- Smaller companies can develop algorithms
- Faster iteration on individual components
- Competitive pressure improves all devices
For Healthcare
- Easier data integration across platforms
- Standardized data formats
- Improved clinical decision support
Current Interoperable Systems
| Component Type | Examples | |----------------|----------| | iCGM | Dexcom G6, G7 | | ACE Pump | Tandem t:slim X2, Omnipod 5 | | AID Algorithm | Control-IQ, Omnipod 5 algorithm |
Challenges
Technical
- Bluetooth reliability between devices
- Data format standardization
- Security across device boundaries
Regulatory
- Complex approval pathways
- Liability across multiple manufacturers
- Post-market surveillance
Future Directions
- More devices achieving interoperable status
- Standardized APIs and data formats
- Cloud-based algorithm updates
- Smartphone-based control options